Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pfizer

26.73
+0.49001.87%
Post-market: 26.67-0.0600-0.22%19:59 EST
Volume:54.34M
Turnover:1.45B
Market Cap:151.49B
PE:18.93
High:26.89
Open:26.40
Low:26.18
Close:26.24
Loading ...

Robert F. Kennedy Jr. Gets Confirmed as Top U.S. Health Official -- Barrons.com

Dow Jones
·
14 Feb

RFK Jr. Confirmed as HHS Head by Senate, Bloomberg Reports

MT Newswires Live
·
14 Feb

Market Chatter: RFK Jr. Confirmed as HHS Head by Senate

MT Newswires Live
·
14 Feb

Pfizer Says Talzenna Combination Improves Overall Survival in Prostate Cancer Study

MT Newswires Live
·
14 Feb

Pfizer says Talzenna, Xtandi combination improved OS in mCRPC

TIPRANKS
·
13 Feb

Pfizer Inc - First Parp + Arpi Combination Shows Significant Os Improvement in Mcrpc

THOMSON REUTERS
·
13 Feb

Pfizer Inc - Talzenna + Xtandi Improves Median Os by 9 Months in Unselected Patients

THOMSON REUTERS
·
13 Feb

Pfizer’s Talzenna® in Combination With Xtandi® Improves Survival Outcomes in Metastatic Castration Resistant Prostate Cancer

THOMSON REUTERS
·
13 Feb

Pfizer Inc - Talzenna + Xtandi Shows 20% Reduction in Risk of Death in Cohort 1

THOMSON REUTERS
·
13 Feb

Pfizer Inc - Talzenna + Xtandi Safety Profile Consistent With Known Profiles

THOMSON REUTERS
·
13 Feb

Investor With $1M Portfolio Earning $61,000 In Dividends Reveals 10 Top Picks, Says 'I'm Considering Aggressive Growth – What Would You Do?'

Benzinga
·
13 Feb

Are Investors Being Too Paranoid About Pfizer Stock?

Motley Fool
·
13 Feb

3 Brand-Name, Ultra-High-Yield Dividend Stocks Patient Investors Can Confidently Buy With $300 Right Now

Motley Fool
·
13 Feb

Pfizer Gets US FDA Approval for Adcetris Combination Regimen for Large B-Cell Lymphoma

MT Newswires Live
·
13 Feb

Pfizer Receives Expanded FDA Approval for Cancer Treatment

Dow Jones
·
13 Feb

Pfizer’s Adcetris combination regimen approved by FDA for r/r DLBCL

TIPRANKS
·
13 Feb